4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000085
Options or other derivatives
- Chief Medical Officer acquired 3,000 shares (grant or award)
- Chief Medical Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-18 | Exercise or conversion : show line 1 in the form Performance share units | −3,000 | 9,000 | D |
| 2026-06-18 | Grant or award : show line 2 in the form Restricted stock units | +3,000 | 3,000 | D |
Loading xslF345X06/wk-form4_1782249348.xml…